SEC Tracker
Get the app

Tempest Therapeutics TPST

Tempest Therapeutics faces Nasdaq delisting risk

Form
8-K
Filed
Importance
Major
  1. Received Nasdaq notice for bid price below $1.00
  2. 180 days to regain compliance until May 3, 2027
  3. Potential for additional 180-day period if meeting other standards

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Tempest Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. ProMIS Neurosciences PMN public float $30M, Jun 30, 2025
  2. Provectus Biopharmaceuticals PVCT public float $31M, Jun 30, 2025
  3. Cumberland Pharmaceuticals CPIX public float $29M, Jun 30, 2025
  4. Rockwell Medical RMTI public float $29M, Jun 30, 2025
  5. Champions Oncology CSBR public float $29M, Oct 31, 2025

Data on this page was fetched . The filing on SEC.gov is the record.